RESUMO
BACKGROUND AND OBJECTIVE: The therapeutic rationale of low-energy pulsed CO(2) laser coagulation mode has not been clarified yet. We conducted this study to characterize the effect of low-energy pulsed CO(2) laser coagulation mode irradiation of the rat gingiva in terms of the expression of heat shock proteins. MATERIAL AND METHODS: Laser irradiation was achieved with the parameters of 5 W, 600 mus pulse duration, and fluence of 326 J/cm(2). The gingiva dissected at different times after irradiation was processed for immunohistochemical examination of the expression of the heat shock proteins, Hsp70 and Hsp25. RESULTS: One hour after irradiation, the epithelial keratinocytes facing the laser wound exhibited an overexpression of Hsp70 in their nucleus. The connective tissue cells facing the laser wound, which included fibroblasts and capillary endothelial cells, showed de novo expression of Hsp70 at 3 h post-irradiation, the level of which peaked at 1 d and thereafter decreased. An enhanced and/or de novo expression of Hsp25 in the connective tissue cells facing the laser wound became evident at 3 h after irradiation, and after 1 d the Hsp25-expressing cells increased in number and spread over the wound as wound repair progressed. There was a temporospatial difference in the expression pattern between Hsp70 and Hsp25, with only a few cells appearing to co-express both heat shock proteins. CONCLUSION: The CO(2) laser treatment in coagulation mode produced the expression of heat shock proteins, and the findings suggest that while Hsp70 mainly conferred cell protection, Hsp25 was involved in the progress of wound repair as well as cell protection.
Assuntos
Gengiva/efeitos da radiação , Proteínas de Choque Térmico HSP27/análise , Proteínas de Choque Térmico HSP70/análise , Fotocoagulação a Laser/métodos , Lasers de Gás/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Animais , Capilares/patologia , Capilares/efeitos da radiação , Contagem de Células , Núcleo Celular/efeitos da radiação , Núcleo Celular/ultraestrutura , Células do Tecido Conjuntivo/patologia , Células do Tecido Conjuntivo/efeitos da radiação , Citoplasma/efeitos da radiação , Citoplasma/ultraestrutura , Cemento Dentário/patologia , Cemento Dentário/efeitos da radiação , Células Endoteliais/patologia , Células Endoteliais/efeitos da radiação , Endotélio Vascular/patologia , Endotélio Vascular/efeitos da radiação , Células Epiteliais/patologia , Células Epiteliais/efeitos da radiação , Fibroblastos/patologia , Fibroblastos/efeitos da radiação , Gengiva/patologia , Gengivectomia/métodos , Queratinócitos/patologia , Queratinócitos/efeitos da radiação , Masculino , Osteoblastos/patologia , Osteoblastos/efeitos da radiação , Ligamento Periodontal/patologia , Ligamento Periodontal/efeitos da radiação , Ratos , Ratos Wistar , Regeneração/fisiologia , Fatores de Tempo , Cicatrização/fisiologiaRESUMO
BACKGROUND: Falecalcitriol is a novel vitamin D analog, which has a greater potential to suppress parathyroid hormone (PTH) and a longer half-life. There are few studies to compare clinical effects of oral falecalcitriol treatment with those of intravenous calcitriol treatment. METHODS: Twenty-one patients with moderate to severe SHPT were included in a random 2 x 2 crossover trial with the two vitamin D analogs (12 weeks for each treatment). The primary endpoint measure was a decrease in serum intact PTH (iPTH) level, and the secondary outcome measures included changes in serum calcium (Ca), phosphate (P), and metabolic bone marker levels. RESULTS: Both treatments decreased iPTH and whole PTH (wPTH) levels by similar degrees (iPTH, -200.1 +/- 107.0 with falecalcitriol vs. -200.8 +/- 114.9 pg/ml with calcitriol, p = 0.9895; wPTH, -137.1 +/- 73.1 with falecalcitriol vs. -120.4 +/- 81.1 pg/ml with calcitriol, p = 0.5603). Serum Ca, P, and Ca x P product levels at the end of each treatment were comparable and the frequencies of hypercalcemia and hyperphosphatemia were also similar during each treatment period. Although intravenous calcitriol treatment significantly changed intact osteocalcin and cross-linked N-telopeptide of type I collagen after 12 weeks, oral falecalcitriol treatment did not change any bone metabolic marker level. CONCLUSION: The present study showed that oral falecalcitriol treatment is effective for PTH suppression, and Ca and P metabolism in hemodialysis patients with moderate to severe SHPT, as well as intravenous calcitriol administration.
Assuntos
Conservadores da Densidade Óssea/administração & dosagem , Calcitriol/análogos & derivados , Calcitriol/administração & dosagem , Hiperparatireoidismo Secundário/tratamento farmacológico , Administração Oral , Fosfatase Alcalina/sangue , Biomarcadores/sangue , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/metabolismo , Cálcio/sangue , Colágeno Tipo I/sangue , Colágeno Tipo I/efeitos dos fármacos , Estudos Cross-Over , Feminino , Humanos , Hiperparatireoidismo Secundário/etiologia , Injeções Intravenosas , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Osteocalcina/sangue , Osteocalcina/efeitos dos fármacos , Hormônio Paratireóideo/sangue , Peptídeos/sangue , Peptídeos/efeitos dos fármacos , Fósforo/sangue , Diálise Renal/efeitos adversos , Resultado do TratamentoRESUMO
BACKGROUND: Despite prophylactic measures, hypotension remains a common side-effect of spinal anaesthesia for parturients. Electroacupuncture at the Neiguan (PC-6) and Jianshi (PC-5) points influences haemodynamics. We thus hypothesized that transcutaneous electrical nerve stimulation (TENS) at traditionally used acupuncture points would reduce the severity of hypotension after spinal anaesthesia in patients undergoing Caesarean section. METHODS: After obtaining approval from the local ethics committee and written informed patient consent, 36 singleton parturients undergoing Caesarean section under spinal anaesthesia were randomized into three groups. The control group received no treatment, and the acupoint and non-acupoint groups received TENS at the PC-5 and PC-6 points of both arms and non-acupoints of both shoulders, respectively. RESULTS: The median (range) of the lowest recorded systolic blood pressure was significantly higher in the acupoint group compared with the other groups and that of the non-acupoint group was higher than that of the control group [control, 70 (68-82) mm Hg; acupoint, 94 (84-109) mm Hg; non-acupoint, 81 (70-92) mm Hg: P<0.001]. Significantly more parturients in the control and non-acupoint groups experienced hypotension [control, 10 (83%); acupoint, 4 (33%); non-acupoint, 10 (83%): P=0.013]. More ephedrine was required to maintain arterial blood pressure in the control and non-acupoint groups. CONCLUSIONS: TENS on the traditional acupuncture points reduced the severity and incidence of hypotension after spinal anaesthesia in parturients.
Assuntos
Pontos de Acupuntura , Anestesia Obstétrica/efeitos adversos , Raquianestesia/efeitos adversos , Cesárea , Hipotensão/prevenção & controle , Estimulação Elétrica Nervosa Transcutânea/métodos , Adulto , Anestesia Obstétrica/métodos , Pressão Sanguínea , Feminino , Frequência Cardíaca , Humanos , Hipotensão/etiologia , Hipotensão/fisiopatologia , GravidezRESUMO
Little is known concerning the role of concurrent chemoradiation (CCRT) in the management of carcinoma of the cervical esophagus. We retrospectively evaluated our treatment approach for patients with cervical esophageal cancer with special emphasis on CCRT with or without surgery. Medical records of 21 consecutive patients with cervical esophageal carcinoma treated mainly with CCRT (1997-2004) were reviewed, and factors that influenced patient survival were analyzed retrospectively. Nineteen received CCRT with cisplatin/5-fluorouracil and five underwent curative surgery. Two patients who were deemed unfit for CCRT received radiation therapy alone. All had three-dimensional treatment planning (median total dose, 40 Gy with surgery, 64 Gy without surgery). Of the 19 patients who received CCRT, 11 patients including five who underwent curative surgery achieved initial local control. Neither of the two patients who received radiation therapy alone achieved local control. Among 19 patients who underwent CCRT, 9/11 with T1-3 grade tumors achieved initial local control, but only 2/8 patients with T4 tumors (P = 0.011, chi(2) test) achieved initial local control. No patient without initial local control survived > 20 months compared with 2-year and 5-year survival rates of 60% and 40% in those who achieved initial local control (P = 0.038). No patient with T4 tumors survived > 18 months, whereas 2- and 5-year survival rates were 62% and 41%, respectively, in those with T1-3 tumors (P = 0.006). The significant effect of T-classification on survival was maintained when analyzed among 19 patients who received CCRT. CCRT shows promise for cervical esophageal carcinoma. T-classification and initial local control had significant impact on survival.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma de Células Escamosas/terapia , Neoplasias Esofágicas/terapia , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/mortalidade , Carcinoma de Células Escamosas/patologia , Quimioterapia Adjuvante , Cisplatino/administração & dosagem , Neoplasias Esofágicas/mortalidade , Neoplasias Esofágicas/patologia , Esofagectomia , Feminino , Fluoruracila/administração & dosagem , Seguimentos , Humanos , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Radioterapia Adjuvante , Estudos RetrospectivosAssuntos
Materiais Biocompatíveis/uso terapêutico , Regeneração Óssea/fisiologia , Osso e Ossos/metabolismo , Osteogênese/fisiologia , Engenharia Tecidual/métodos , Animais , Osso e Ossos/citologia , Osso e Ossos/diagnóstico por imagem , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Sobrevivência de Enxerto/efeitos dos fármacos , Sobrevivência de Enxerto/fisiologia , Substâncias de Crescimento/farmacologia , Substâncias de Crescimento/uso terapêutico , Humanos , Imageamento Tridimensional/métodos , Imageamento Tridimensional/tendências , Engenharia Tecidual/tendências , Tomografia Computadorizada por Raios X/métodos , Tomografia Computadorizada por Raios X/tendênciasRESUMO
A series of 27 hydrolyzable tannins and related compounds was tested for antiparasitic effects against both extracellular promastigote and intracellular amastigote Leishmania donovani organisms. In parallel, the compounds were evaluated for their immunomodulatory effects on macrophage functions, including release of nitric oxide (NO), tumour necrosis factor-alpha (TNF-alpha) and interferon (IFN)-like properties using several functional assays. Of the series of polyphenols tested, only gallic acid (54 microM NO) and its methyl ester (32 microM NO) induced murine macrophage-like RAW 264.7 cells to release NO in appreciable amounts (IFN-gamma/LPS 119 microM NO). The in vitro TNF-inducing potential of the polyphenols examined increased in the order of oligomeric ellagitannins (EC(50) > 25 microg/ml) < monomeric ellagitannins, gallotannins (EC(50) 8.5 to > 25 microg/ml) < C-glucosidic ellagitannins, dehydroellagitannins (EC(50) 0.6 - 2.8 microg/ml) at the host cell subtoxic concentration of 50 microg/ml. Furthermore, promastigotes of Leishmania donovani were assayed in the presence of these polyphenols and the results showed that none of the compounds was significantly toxic (EC(50) > 25 microg/ml) to the extracellular forms. In contrast, all polyphenols showed pronounced antileishmanial activities (EC(50) < 0.4 - 12.5 versus 7.9 microg/ml for Pentostam) against intracellular amastigotes of L. donovani residing within RAW cells. Noteworthy, most compounds exhibited low cytotoxicity against the murine host cells (EC(50) >25 microg/ml). Furthermore, some ellagitannins and the majority of dehydroellagitannins induced potent interferon-like activities as reflected by inhibition of the cytopathic effect of encephalomyocarditis virus on fibroblast L929 cells. This is the first report on hydrolyzable tannins as a new class of natural products with leishmanicidal activity including their potential for inducing the release of NO, TNF and IFN-like activity in macrophage-like RAW cells.
Assuntos
Antiparasitários/farmacologia , Leishmania donovani/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Óxido Nítrico/metabolismo , Taninos/farmacologia , Fator de Necrose Tumoral alfa/efeitos dos fármacos , Animais , Linhagem Celular , Macrófagos/metabolismo , Macrófagos/parasitologia , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Extratos Vegetais/farmacologia , Estereoisomerismo , Taninos/química , Taninos/metabolismo , Fator de Necrose Tumoral alfa/metabolismoRESUMO
To investigate the effects of ascorbic acid deficiency on the pathogenesis of hypertension and/or its complications, we established a rat strain with both genetic hypertension and a defect of ascorbic acid biosynthesis. The od gene (L-gulono-gamma-lactone oxidase gene) of the ODS (Osteogenic Disorder Shionogi) rat, which is a rat mutant unable to synthesize ascorbic acid, was introduced into spontaneously hypertensive rats (SHR), and a novel congenic strain, SHR-od, was established. SHR-od showed scurvy when fed an ascorbic acid-free diet. Systolic blood pressure of male SHR-od began to increase at 9 weeks of age and reached 190-200 mmHg at 20 weeks of age. In 25-week-old SHR-od, ascorbic acid deficiency when fed an ascorbic acid-free diet for 6 weeks caused a remarkable reduction of blood pressure to lower than 110 mmHg. The wall to lumen ratio of the testicular artery in ascorbic acid-deficient SHR-od was lower than that of the control rats. When rats were fed a diet supplemented with ascorbic acid (300 mg/kg), ascorbic acid concentration in SHR-od was lower in the serum and liver than that in ODS rats. These results indicate that ascorbic acid could be closely related to the development of hypertension in SHR-od. We believe that SHR-od will be a useful model for experimental studies on hypertension and its complications, since all of them suffer from hypertension spontaneously and the level of ascorbic acid deficiency in these rats could be controlled at will both in concentration and duration.
Assuntos
Deficiência de Ácido Ascórbico/genética , Modelos Animais de Doenças , Hipertensão/genética , Ratos Endogâmicos SHR/genética , Envelhecimento/fisiologia , Fosfatase Alcalina/sangue , Animais , Animais Congênicos , Artérias/efeitos dos fármacos , Artérias/patologia , Ácido Ascórbico/sangue , Ácido Ascórbico/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Epinefrina/sangue , Heterozigoto , Hipertensão/sangue , L-Gulonolactona Oxidase , Fígado/enzimologia , Masculino , Norepinefrina/sangue , Ratos , Ratos Mutantes , Desidrogenase do Álcool de Açúcar/genética , Testículo/irrigação sanguínea , Testículo/patologiaRESUMO
We found that an extract of Arctostaphylos uva-ursi markedly reduced the MICs of beta-lactam antibiotics, such as oxacillin and cefmetazole, against methicillin-resistant Staphylococcus aureus. We isolated the effective compound and identified it as corilagin. Corilagin reduced the MICs of various beta-lactams by 100- to 2,000-fold but not the MICs of other antimicrobial agents tested. The effect of corilagin and oxacillin was synergistic. Corilagin showed a bactericidal action when added to the growth medium in combination with oxacillin.
Assuntos
Antibacterianos/farmacologia , Glucosídeos/farmacologia , Resistência a Meticilina , Staphylococcus aureus/efeitos dos fármacos , Cromatografia por Troca Iônica , Sinergismo Farmacológico , Taninos Hidrolisáveis , Testes de Sensibilidade Microbiana , Oxacilina/farmacologia , Penicilinas/farmacologia , Extratos Vegetais/farmacologia , Folhas de Planta/químicaRESUMO
Four new isoflavonoids were isolated along with six known related compounds from a rhizome of Belamcanda chinensis (Iridaceae), and their structures were characterized as 6''-O-p-hydroxybenzoyliridin, 6''-O-vanilloyliridin, 5,6,7,3'-tetrahydroxy-4'-methoxyisoflavone and 2,3-dihydroirigenin, respectively, on the basis of spectroscopic methods and chemical evidence.
Assuntos
Iridaceae/química , Isoflavonas/química , Indicadores e Reagentes , Isoflavonas/isolamento & purificação , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Extratos Vegetais/análise , Raízes de Plantas/química , Espectrofotometria UltravioletaRESUMO
Various plant-derived essential oils (EOs) have traditionally been used in the treatment of mental disorders, despite a lack of scientific evidence. In a previous study, we demonstrated that certain EOs possess behavioral effects, a finding that supports our original hypotheses that EOs possess psychoactive actions. The present study was conducted in order to obtain further evidence to support our hypothesis. Peppermint oil, a type of EO, is believed to be effective for treating mental fatigue. When the oil was administered intraperitoneally to ICR mice, the ambulatory activity of mice increased dramatically. We identified alpha-pinene, beta-pinene, (R)-(+)-limonene, 1,8-cineol, isomenthone, menthone, menthol, (R)-(+)-pulegone, menthyl acetate and caryophyllene as constituent elements of peppermint oil by GC-MS analysis. We then examined the effect of each constituent element of peppermint oil on ambulatory activity in mice. Intraperitoneal administration of 1,8-cineol, menthone, isomenthone, menthol, (R)-(+)-pulegone, menthyl acetate and caryophyllene significantly increased ambulatory activity in mice, suggesting that these chemicals are the behaviorally active elements of peppermint oil. Intravenous administration of these substances to mice induced a significant increase in ambulatory activity at much lower doses. The present study provides further evidence demonstrating that EOs possess pharmacological actions on behavior. In addition, our finding revealed that the action of peppermint oil comes from its constituent elements.
Assuntos
Monoterpenos , Atividade Motora/efeitos dos fármacos , Parassimpatolíticos/farmacologia , Óleos de Plantas/farmacologia , Animais , Antipruriginosos/farmacologia , Monoterpenos Bicíclicos , Relação Dose-Resposta a Droga , Masculino , Mentha piperita , Mentol/farmacologia , Camundongos , Camundongos Endogâmicos ICR , Atividade Motora/fisiologia , Óleos Voláteis/análise , Óleos Voláteis/farmacologia , Parassimpatolíticos/análise , Óleos de Plantas/análise , Terpenos/farmacologiaRESUMO
OBJECTIVE: Polyneuropathy has been reported after gastrectomy performed to treat various lesions. Although thiamine deficiency is a possible cause of this neuropathy, the pathogenesis still remains to be clarified. Seventeen patients with peripheral neuropathy with thiamine deficiency after gastrectomy are described. METHODS: Seventeen patients with polyneuropathy after gastrectomy accompanied by thiamine deficiency were selected. Patients were restricted to those with total or subtotal gastric resection to treat ulcer or neoplasm. Patients who had undergone operations to treat morbid obesity were excluded. RESULTS: Intervals between the operation and onset of neuropathy varied from 2 months to 39 years. Most patients did not seem malnourished. Serum concentrations of B vitamins other than thiamine were nearly normal. Symmetric motor-sensory polyneuropathy, predominantly involving the lower limbs, had progressed over intervals varying from 3 days to 8 years. Relative degrees of motor and sensory impairment also varied extensively. Some cases that progressed rapidly mimicked Guillain-Barré syndrome. Electrophysiological and pathological findings were those of axonal neuropathy. Substantial functional recovery from polyneuropathy was seen in most patients by 3 to 6 months after initiating thiamine supplementation. Motor recovery was better than sensory recovery. CONCLUSIONS: Various symptoms were seen in patients with postgastrectomy neuropathy. Thiamine deficiency should be considered in the differential diagnosis of motor-sensory polyneuropathy after gastrectomy.
Assuntos
Gastrectomia/efeitos adversos , Polineuropatias/etiologia , Deficiência de Tiamina/etiologia , Atividades Cotidianas , Adulto , Idoso , Biópsia , Diagnóstico Diferencial , Progressão da Doença , Feminino , Gastrectomia/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Condução Nervosa , Polineuropatias/sangue , Polineuropatias/diagnóstico , Polineuropatias/fisiopatologia , Recuperação de Função Fisiológica , Neoplasias Gástricas/cirurgia , Úlcera Gástrica/cirurgia , Tiamina/sangue , Tiamina/uso terapêutico , Deficiência de Tiamina/sangue , Deficiência de Tiamina/diagnóstico , Deficiência de Tiamina/tratamento farmacológico , Deficiência de Tiamina/fisiopatologia , Fatores de TempoRESUMO
OBJECTIVES: To prospectively assess the efficacy of transurethral holmium (Ho):YAG laser prostatectomy using a side-firing fiber in patients with bladder outlet obstruction due to benign prostatic enlargement (BPE) from the standpoint of urodynamics. METHODS: 32 male patients with BPE aged 53-83 (mean 69.4) years were operated on. All patients, excluding 3 with urinary retention, were evaluated with the International Prostatic Symptom Score (IPSS), Quality of Life (QOL) score and uroflowmetry up to 12 months postoperatively, and a pressure/flow study was performed before and 3 months after the operation. RESULTS: The total IPSS score, QOL score, average and maximum flow rates improved significantly (p<0.0001) at 12 months postoperatively. In the pressure/flow study, detrusor opening pressure, maximum detrusor pressure, detrusor pressure at maximum flow, minimum urethral opening pressure, and Abrams-Griffiths number decreased significantly (p<0.0001, p = 0.0001, p<0.0001, p = 0.0019 and p<0.0001, respectively) 3 months postoperatively. Detrusor instability disappeared in 12 of 17 patients and remained in 2. CONCLUSIONS: Transurethral Ho:YAG laser prostatectomy was found to be effective for the treatment of bladder outlet obstruction due to BPE.
Assuntos
Terapia a Laser/métodos , Hiperplasia Prostática/cirurgia , Ressecção Transuretral da Próstata/métodos , Obstrução do Colo da Bexiga Urinária/cirurgia , Idoso , Idoso de 80 Anos ou mais , Hólmio , Humanos , Terapia a Laser/instrumentação , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Hiperplasia Prostática/complicações , Resultado do Tratamento , Obstrução do Colo da Bexiga Urinária/etiologia , Obstrução do Colo da Bexiga Urinária/fisiopatologia , Urodinâmica/efeitos da radiaçãoAssuntos
Colecistite/terapia , Colelitíase/terapia , Nutrição Enteral , Nutrição Parenteral , Doença Aguda , Aminoácidos de Cadeia Ramificada/administração & dosagem , Citocinas/metabolismo , Drenagem , Nutrição Enteral/métodos , Ácidos Graxos Ômega-3/administração & dosagem , Humanos , Nutrição Parenteral/métodosRESUMO
Two new megastigmane glycosides, eriojaposides A (1) and B (2), and a new acylated triterpenoid (3) were isolated along with nine known compounds from a leaf extract of Eriobotrya japonica. The structures of 1--3 were characterized as (6R,9R)-3-oxo-alpha-ionyl-9-O-beta-xylopyranosyl-(1' '-->6')-beta-glucopyranoside, (6R,9R)-3-oxo-alpha-ionyl-9-O-alpha-rhamnopyranosyl-(1' '-->6')-beta-glucopyranoside, and 3 alpha-trans-feruloyloxy-2 alpha-hydroxyurs-12-en-28-oic acid, respectively, on the basis of spectral and chemical evidence.
Assuntos
Glicosídeos/isolamento & purificação , Norisoprenoides , Plantas Medicinais/química , Triterpenos/isolamento & purificação , Ásia , Glicosídeos/química , Hidrólise , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Triterpenos/químicaRESUMO
In view of recent studies on the mechanisms of the survival of peripheral memory T cells, we tested the biologic role of pectate lyase, a pectin-degrading enzyme, as the cross-reactive antigen required for the recurring survival signals for human T cells specific for Cha o 1, a pollen allergen molecule of the Japanese cypress. We determined a 16-mer epitope peptide for the T-cell clone, and prepared synthetic oligopeptides of homologous regions in putative pectate lyase of other plants. Of these homologous peptides, ZePel (Zinnia elegans), ban 17 (banana), and Amb a 1.1 (short ragweed) induced strong proliferative responses of the Cha o 1-specific T-cell clone in vitro. In addition, suboptimal doses of peptide homologs derived from banana and short ragweed enhanced the survival potency of this T-cell clone without detectable proliferative responses to the peptides. When there was no antigen stimulation, the T-cell clone decreased in viable cell number and lost antigen-specific proliferation activity on day 6 during in vitro incubation. On the other hand, T-cell clones incubated with these survival-inducing peptides maintained proliferative activity to Cha o 1 even on day 9. Serum derived from the donor patient did not contain detectable levels of IgE specific to banana or short ragweed by CAP-RAST. These results show that human T cells specific for pollen allergen seem to use cross-reactive pectate lyase peptides to deliver survival signals even in the absence of pollen allergen, and memory T cells maintained in such a manner might be functioning at the onset of allergic pollinosis, although pollen allergens are seasonal.
Assuntos
Alérgenos , Hipersensibilidade/imunologia , Imunoglobulina E/sangue , Memória Imunológica/imunologia , Proteínas de Plantas/efeitos adversos , Proteínas de Plantas/imunologia , Pólen/imunologia , Polissacarídeo-Liases/imunologia , Linfócitos T/imunologia , Antígenos de Plantas , Reações Cruzadas/imunologia , Frutas/enzimologia , Humanos , Imunoglobulina E/imunologia , Liliaceae/enzimologia , Solanum lycopersicum/enzimologia , Medicago sativa/enzimologia , Pisum sativum/enzimologia , Proteínas de Plantas/genética , Polissacarídeo-Liases/genética , Teste de Radioalergoadsorção , Homologia de Sequência de Aminoácidos , Transdução de Sinais/imunologia , Árvores , Zingiberales/enzimologiaRESUMO
OBJECTIVES: This study examines the efficacy of FTY720 (FTY), a new immunosuppressor, in the treatment of acute viral myocarditis in a murine model. BACKGROUND: Immunosuppressive agents have no proven therapeutic efficacy in experimental or clinical myocarditis. METHODS: Encephalomyocarditis virus was inoculated i.p. in DBA/2 mice on day 0. Postinoculation treatment consisted of FTY 10 mg/kg/day p.o. (FTY group), or cyclosporine A (CsA) 40 mg/kg/day p.o. (CsA group) or distilled water p.o. only (control group). Survival until day 14, as well as cardiac histopathology, virus concentrations, cytokines (interleukin [IL]-2, IL-12, interferon [IFN]-gamma and tumor necrosis factor [TNF]-alpha) and nitric oxide (NO) on day 5 were examined. RESULTS: In the control and CsA groups, all mice died within 10 and 7 days, respectively. However, in the FTY group, 27% of the animals survived up to day 14. Compared with the control group, 1) histological scores were significantly lower in the FTY group but unchanged in the CsA group; 2) virus concentration was significantly higher in the CsA group but not in the FTY group; 3) expressions of IL-2, IL-12 and IFN-gamma in the heart were suppressed in both the FTY and CsA groups, though suppression was weaker in the FTY group; 4) TNF-alpha and NO were significantly increased in the CsA group but not in the FTY group. CONCLUSIONS: FTY720 had a significant therapeutic effect in acute experimental myocarditis without inducing excessive virus replication. This report is the first to describe a beneficial effect by an immunosuppressive agent in the treatment of acute viral myocarditis.
Assuntos
Infecções por Cardiovirus/complicações , Modelos Animais de Doenças , Vírus da Encefalomiocardite , Imunossupressores/uso terapêutico , Miocardite/tratamento farmacológico , Miocardite/virologia , Propilenoglicóis/uso terapêutico , Doença Aguda , Animais , Avaliação Pré-Clínica de Medicamentos , Cloridrato de Fingolimode , Humanos , Imunossupressores/farmacologia , Interferon gama/análise , Interleucina-12/análise , Interleucina-2/análise , Masculino , Camundongos , Camundongos Endogâmicos DBA , Miocardite/diagnóstico , Miocardite/imunologia , Miocardite/mortalidade , Óxido Nítrico/análise , Modelos de Riscos Proporcionais , Propilenoglicóis/farmacologia , Índice de Gravidade de Doença , Esfingosina/análogos & derivados , Análise de Sobrevida , Resultado do Tratamento , Fator de Necrose Tumoral alfa/análiseRESUMO
BACKGROUND: Cystinuria has been proposed to be an inherited defect of apical membrane transport systems for cystine and basic amino acids in renal proximal tubules. Although the mutations of the recently identified transporter BAT1/b(0,+)AT have been related to nontype I cystinuria, the function and localization of human BAT1 (hBAT1)/b(0,+)AT have not been well characterized. METHODS: The cDNA encoding hBAT1 was isolated from human kidney. Fluorescence in situ hybridization was performed to map the hBAT1 gene on human chromosomes. Tissue distribution and localization of expression were examined by Northern blot and immunohistochemical analyses. hBAT1 cDNA was transfected to COS-7 cells with rBAT cDNA, and the uptake and efflux of 14C-labeled amino acids were measured to determine the functional properties. The roles of protein kinase-dependent phosphorylation were investigated using inhibitors or activators of protein kinases. RESULTS: The hBAT1 gene was mapped to 19q12-13.1 on the human chromosome, which is the locus of nontype I cystinuria. hBAT1 message was expressed predominantly in kidney. hBAT1 protein was localized in the apical membrane of proximal tubules in human kidney. When expressed in COS-7 cells with a type II membrane glycoprotein rBAT (related to b(0,+)-amino acid transporter), hBAT1 exhibited the transport activity with the properties of amino acid transport system b(0,+), which transported cystine as well as basic and neutral amino acids presumably via a substrate exchange mechanism. BAT1-mediated transport was reduced by the protein kinase A activator and enhanced by the tyrosine kinase inhibitor. CONCLUSIONS: hBAT1 exhibited the properties expected for a transporter subserving the high-affinity cystine transport system in renal proximal tubules. The hBAT1 gene was mapped to the locus of nontype I cystinuria, confirming the involvement of hBAT1 in cystinuria.
Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Transportadores de Cassetes de Ligação de ATP/metabolismo , Cistinúria/genética , Cistinúria/metabolismo , Sequência de Aminoácidos , Aminoácidos/metabolismo , Animais , Sequência de Bases , Transporte Biológico Ativo , Células COS , Mapeamento Cromossômico , RNA Helicases DEAD-box , Primers do DNA/genética , DNA Complementar/genética , Feminino , Humanos , Hibridização in Situ Fluorescente , Técnicas In Vitro , Dados de Sequência Molecular , Fosforilação , Proteínas Quinases/metabolismo , RNA Helicases , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Homologia de Sequência de Aminoácidos , Distribuição Tecidual , XenopusAssuntos
Adenocarcinoma/patologia , Infecções por Helicobacter/complicações , Linfoma de Zona Marginal Tipo Células B/complicações , Linfoma de Zona Marginal Tipo Células B/microbiologia , Neoplasias Gástricas/patologia , Adenocarcinoma/complicações , Idoso , Endoscopia Gastrointestinal , Feminino , Infecções por Helicobacter/microbiologia , Infecções por Helicobacter/patologia , Infecções por Helicobacter/terapia , Helicobacter pylori/isolamento & purificação , Humanos , Linfoma de Zona Marginal Tipo Células B/patologia , Linfoma de Zona Marginal Tipo Células B/terapia , Neoplasias Gástricas/complicaçõesRESUMO
OBJECTIVES: To perform a randomized comparative study investigating the urodynamic effects of functional magnetic stimulation (FMS) and functional electrical stimulation (FES) on the inhibition of detrusor overactivity. METHODS: Thirty-two patients with urinary incontinence due to detrusor overactivity (15 men, 17 women; age 62. 3 +/- 16.6 years) were randomly assigned to two treatment groups (15 patients in the FMS group and 17 in the FES group). Stimulation was applied continuously at 10 Hz in both groups. For FMS, the magnetic stimulator unit was set on an armchair type seat and had a concave-shaped coil, so that the patients could sit during stimulation. For FES, a vaginal electrode was used in the women and a surface electrode on the dorsal part of the penis was used in the men. Cystometry was performed before and during the stimulation. RESULTS: The bladder capacity at the first desire to void and the maximum cystometric capacity increased significantly during stimulation compared with prestimulation levels in both groups (P = 0.0054 and 0.0026, respectively, in the FMS group and P = 0.0015 and 0.0229, respectively, in the FES group). However, the increase in the maximum cystometric capacity was significantly (P = 0.0135) greater in the FMS group (114.2 +/- 124.1 mL or an increase of 105. 5% +/- 130.4% compared with the pretreatment level) than that in the FES group (32.3 +/- 56.6 mL or an increase of 16.3% +/- 33.9%). Detrusor overactivity was abolished in 3 patients in the FMS group but not in any patient in the FES group. CONCLUSIONS: Although both treatments were effective, the inhibition of detrusor overactivity appeared greater in the FMS group than in the FES group.